IDT Biologika


IDT Biologika is a global biopharmaceutical contract development and manufacturing organization that specializes in the production of innovative vaccines, viral vectors for gene & immune therapeutics, oncolytic viruses, protein-based vaccines including virus-like particles and other sterile liquid and lyophilized biologics to improve human health worldwide.

We offer clients in B2B business a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes process development, drug substance manufacturing up to BSL-3, sterile dosage filling, packaging, quality control & analytics and cold storage. IDT Biologika handles every step in manufacturing and packaging of small clinical batches and large-scale commercial products.

Our fully integrated services at our sites in Germany and the USA are underscored by our commitment to quality and operational excellence that flows through our best-in-class process and cGMP (up to BSL3) manufacturing capabilities meeting FDA, EMA and ANVISA standards.

We supply our client’s products in vials, pre-filled syringes (with and without safety devices), autoinjectors or as combination products.

IDT Biologika is unique in its ability to accommodate the development, testing and manufacture of products for the world’s leading biopharmaceutical companies. Many human vaccines developed by IDT Biologika, together with international partners, are already in use, fighting infectious diseases such as COVID-19, tuberculosis, AIDS, malaria, cancer, dengue and ebola.

Particularly noteworthy recent collaborations include with the Biomedical Advanced Research and Development Authority (BARDA), an office of the U.S. Department of Health and Human Services, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services, and the Coalition for Epidemic Preparedness Innovations (CEPI).

At its headquarters in Germany, IDT Biologika operates one of Europe’s premiere integrated facilities for end-to-end services from process development through clinical phases I-III to commercial manufacturing. In Rockville, MA, USA we utilize broad capabilities and a depth of technologies for process development and manufacturing of clinical trial material for phases I-II.

Our most important assets are our employees, whose expertise and collaborative nature complement our innovative technologies, resulting in high quality customer service and satisfaction.